These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 15684606)
1. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Biaglow JE; Miller RA Cancer Biol Ther; 2005 Jan; 4(1):6-13. PubMed ID: 15684606 [TBL] [Abstract][Full Text] [Related]
2. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328 [TBL] [Abstract][Full Text] [Related]
3. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Tonissen KF; Di Trapani G Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503 [TBL] [Abstract][Full Text] [Related]
4. The thioredoxin system and cancer therapy: a review. Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788 [TBL] [Abstract][Full Text] [Related]
5. The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila. Cheng Z; Arscott LD; Ballou DP; Williams CH Biochemistry; 2007 Jul; 46(26):7875-85. PubMed ID: 17550271 [TBL] [Abstract][Full Text] [Related]
6. The thioredoxin antioxidant system. Lu J; Holmgren A Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494 [TBL] [Abstract][Full Text] [Related]
7. Targeting the Thioredoxin System for Cancer Therapy. Zhang J; Li X; Han X; Liu R; Fang J Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527 [TBL] [Abstract][Full Text] [Related]
8. Thioredoxin system modulation by plant and fungal secondary metabolites. Dal Piaz F; Braca A; Belisario MA; De Tommasi N Curr Med Chem; 2010; 17(5):479-94. PubMed ID: 19941471 [TBL] [Abstract][Full Text] [Related]
9. Selenium and the thioredoxin and glutaredoxin systems. Björnstedt M; Kumar S; Björkhem L; Spyrou G; Holmgren A Biomed Environ Sci; 1997 Sep; 10(2-3):271-9. PubMed ID: 9315320 [TBL] [Abstract][Full Text] [Related]
10. Motexafin gadolinium: a novel redox active drug for cancer therapy. Magda D; Miller RA Semin Cancer Biol; 2006 Dec; 16(6):466-76. PubMed ID: 17112739 [TBL] [Abstract][Full Text] [Related]
11. Thioredoxin signaling as a target for cancer therapy. Powis G; Kirkpatrick DL Curr Opin Pharmacol; 2007 Aug; 7(4):392-7. PubMed ID: 17611157 [TBL] [Abstract][Full Text] [Related]
12. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples. Montano SJ; Lu J; Gustafsson TN; Holmgren A Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250 [TBL] [Abstract][Full Text] [Related]
13. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction. Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines. Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187 [TBL] [Abstract][Full Text] [Related]
15. Methanosarcina acetivorans utilizes a single NADPH-dependent thioredoxin system and contains additional thioredoxin homologues with distinct functions. McCarver AC; Lessner FH; Soroeta JM; Lessner DJ Microbiology (Reading); 2017 Jan; 163(1):62-74. PubMed ID: 27902413 [TBL] [Abstract][Full Text] [Related]
16. Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells. Myers JM; Antholine WE; Myers CR Toxicology; 2008 Apr; 246(2-3):222-33. PubMed ID: 18328613 [TBL] [Abstract][Full Text] [Related]
17. A Pro to His mutation in active site of thioredoxin increases its disulfide-isomerase activity 10-fold. New refolding systems for reduced or randomly oxidized ribonuclease. Lundström J; Krause G; Holmgren A J Biol Chem; 1992 May; 267(13):9047-52. PubMed ID: 1577742 [TBL] [Abstract][Full Text] [Related]
18. Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system. Sun Y; Rowehl LM; Huang L; Mackenzie GG; Vrankova K; Komninou D; Rigas B Breast Cancer Res; 2012 Jan; 14(1):R20. PubMed ID: 22293394 [TBL] [Abstract][Full Text] [Related]
19. Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems. Go YM; Roede JR; Walker DI; Duong DM; Seyfried NT; Orr M; Liang Y; Pennell KD; Jones DP Mol Cell Proteomics; 2013 Nov; 12(11):3285-96. PubMed ID: 23946468 [TBL] [Abstract][Full Text] [Related]
20. Thioredoxin h isoforms from rice are differentially reduced by NADPH/thioredoxin or GSH/glutaredoxin systems. Shaykholeslam Esfahani E; Shahpiri A Int J Biol Macromol; 2015 Mar; 74():243-8. PubMed ID: 25541357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]